SpyGlass Pharma, Inc.
SGP
$26.20
$1.034.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 234.19M | 251.00M | 107.44M | -- | |
| Total Receivables | 678.00K | 653.00K | 431.00K | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 1.60M | 1.71M | 901.00K | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 236.46M | 253.36M | 108.77M | -- | |
|
|
|||||
| Total Current Assets | 236.46M | 253.36M | 108.77M | -- | |
| Net Property, Plant & Equipment | 6.21M | 4.24M | 3.89M | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 759.00K | 789.00K | 3.21M | -- | |
| Total Assets | 243.43M | 258.39M | 115.87M | -- | |
|
|
|||||
| Total Accounts Payable | 4.16M | 3.51M | 2.70M | -- | |
| Total Accrued Expenses | 1.72M | 882.00K | 2.18M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | 3.56M | 2.27M | 3.71M | -- | |
| Total Other Current Liabilities | 3.56M | 2.27M | 3.71M | -- | |
| Total Current Liabilities | 9.44M | 6.67M | 8.58M | -- | |
|
|
|||||
| Total Current Liabilities | 9.44M | 6.67M | 8.58M | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 1.63M | 1.61M | 1.58M | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 11.07M | 8.27M | 10.17M | -- | |
|
|
|||||
| Common Stock & APIC | 370.78M | 368.66M | 5.89M | -- | |
| Retained Earnings | -138.41M | -118.55M | -104.73M | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 232.36M | 250.11M | -98.84M | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | 204.54M | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | 204.54M | -- | |
|
|
|||||
| Total Common Equity | 232.36M | 250.11M | -98.84M | -- | |
| Total Preferred Equity | -- | -- | 204.54M | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 232.36M | 250.11M | 105.70M | -- | |
|
|
|||||